-Hindustan Times During his town hall address at IIT Delhi, Facebook CEO Mark Zuckerberg said: “Those who don’t have access to the internet cannot sign online petitions.” But how can he decide what is best for them? Recent research by Amba Kak at the Oxford Internet Institute found that financially constrained users prefer buying shorter duration Internet plans (e.g. three days) with all access, as opposed to WhatsApp-only plans that are...

-Livemint.com What’s essential for the unique identification number to continue is a strong law. But what should it look like? A key thrust of the 2012 writ petition filed in the Aadhaar case (Puttaswamy versus Union of India) was that the executive action in implementing Aadhaar was unconstitutional in the absence of a law. Later developments in the case, including the government’s argument that there is no fundamental right to privacy, and...

-Millennium Post New Delhi: Delhi government has tightened the noose around private hospitals that managed to obtain prime government land in the city by promising free treatment to poor patients but have completely denied the facility after getting the land. The government has started the procedure to recover around Rs 203 crore ‘unwarranted profits’ which they had earned by utilising beds reserved for the Economically Weaker Section (EWS) category patients on...

-The Hindustan Times The stereotype of a reporter landing in a new city and then getting political insights from the taxi driver on the way from the airport is not without merit. For a visitor, the first encounter is with the cabbie, and cabbies, as assumed, have not just local knowledge, but much wisdom too. A cabbie’s views often get extrapolated and incorporated into much of the reporting. As true as this...

-The Times of India NEW DELHI: In an attempt to ease norms for testing and introduction of new medicines in the country, the government has taken steps to fast-track approvals for clinical trials as well as launch of drugs already approved in other countries. Pharmaceutical companies planning to launch new drugs already approved outside India after conducting pre-clinical or toxicological studies on animals will not be required to repeat such studies in...